Opportunities and challenges of immuno-oncology: A bibliometric analysis from 2014 to 2023

被引:0
|
作者
Zhang, Siqi [1 ,2 ,3 ]
Miao, Lina [4 ]
Tian, Xiaoxia [1 ]
Yang, Bingxu [1 ]
Luo, Baoping [1 ,2 ,3 ]
机构
[1] Hubei Univ Chinese Med, Sch Clin Tradit Chinese Med, Wuhan, Peoples R China
[2] Hubei Univ Chinese Med, Dept Oncol, 856 Luoyu Rd, Wuhan, Hubei, Peoples R China
[3] Hubei Prov Acad Tradit Chinese Med, Dept Oncol, Wuhan, Peoples R China
[4] China Acad Chinese Med Sci, Xiyuan Hosp, Beijing, Peoples R China
关键词
Immuno-oncology; immunotherapy; CiteSpace; bibliometrics; visual analysis; CANCER; IMMUNOTHERAPY; PEMBROLIZUMAB; THERAPY; IPILIMUMAB; CARCINOMA; ANTIBODY;
D O I
10.1080/21645515.2024.2440203
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
The emergence of immuno-oncology (IO) has led to revolutionary changes in the field of cancer treatment. Despite notable advancements in this field, a thorough exploration of its full depth and extent has yet to be performed. This study provides a comprehensive overview of publications pertaining to IO. Publications on IO from 2014 to 2023 were retrieved by searching the Web of Science Core Collection database (WoSCC). VOSviewer software and Citespace software were used for the visualized analysis. A total of 1,874 articles have been published in the IO domain. The number of publications and citations has been increasing annually. This study also examines the primary research directions within the field of IO. In conclusion, this study offers a comprehensive overview of the opportunities and challenges associated with IO, illuminating the current status of research and indicating potential future trajectories in this rapidly progressing field. This study provides a comprehensive survey of the current research status and hot spots within the field of IO. It will assist researchers in comprehending the current research emphasis and development trends in this field and offers guidance for future research directions.
引用
收藏
页数:13
相关论文
共 50 条
  • [1] Challenges and Opportunities in Dose Finding in Oncology and Immuno-oncology
    Ji, Yan
    Jin, Jin Y.
    Hyman, David M.
    Kim, Geoffrey
    Suri, Ajit
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2018, 11 (04): : 345 - 351
  • [2] Ten challenges and opportunities in computational immuno-oncology
    Bao, Riyue
    Hutson, Alan
    Madabhushi, Anant
    Jonsson, Vanessa D.
    Rosario, Spencer R.
    Barnholtz-Sloan, Jill S.
    Fertig, Elana J.
    Marathe, Himangi
    Harris, Lyndsay
    Altreuter, Jennifer
    Chen, Qingrong
    Dignam, James
    Gentles, Andrew J.
    Gonzalez-Kozlova, Edgar
    Gnjatic, Sacha
    Kim, Erika
    Long, Mark
    Morgan, Martin
    Ruppin, Eytan
    Valen, David Van
    Zhang, Hong
    Vokes, Natalie
    Meerzaman, Daoud
    Liu, Song
    Van Allen, Eliezer M.
    Xing, Yi
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2024, 12 (10)
  • [3] Immuno-oncology Clinical Trial Design: Limitations, Challenges, and Opportunities
    Baik, Christina S.
    Rubin, Eric H.
    Forde, Patrick M.
    Mehnert, Janice M.
    Collyar, Deborah
    Butler, Marcus O.
    Dixon, Erica L.
    Chow, Laura Q. M.
    CLINICAL CANCER RESEARCH, 2017, 23 (17) : 4992 - 5002
  • [4] IMMUNO-ONCOLOGY COMBINATIONS NOVEMBER 2014
    Talreja, C.
    Prusty, S.
    Jago, C.
    Kibble, A.
    DRUGS OF THE FUTURE, 2014, 39 (11) : 793 - 798
  • [5] Promises and challenges of immuno-oncology from a clinical perspective
    Kunitoh, Hideo M. D.
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2018, 48 (02) : 101 - 102
  • [6] TRENDS AND CHALLENGES IN IMMUNO-ONCOLOGY TRIALS
    Kiernan, B.
    DRUGS OF TODAY, 2016, 52 (07) : 387 - 393
  • [7] Challenges of Toxicity Management in Immuno-Oncology
    Andrews, Stephanie
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2017, 15 (5.5): : 706 - 708
  • [8] Statistical issues and challenges in immuno-oncology
    Chen, Tai-Tsang
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2013, 1
  • [9] A bibliometric analysis of immuno-oncology research: Is a new global leader emerging?
    Lythgoe, Mark
    Lewison, Grant
    Aggarwal, Ajay Kumar
    Booth, Christopher M.
    Lawler, Mark
    Trapani, Dario
    Sengar, Manju
    Sullivan, Richard
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [10] Big opportunities for small molecules in immuno-oncology
    Adams, Jerry L.
    Smothers, James
    Srinivasan, Roopa
    Hoos, Axel
    NATURE REVIEWS DRUG DISCOVERY, 2015, 14 (09) : 603 - 622